Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 ·
Decision snapshot: HIPO stock price vs BBWI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BBWI's multiple
Needs BBWI P/E.
Implied fair value · at HIPO's multiple
Needs HIPO P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HIPO FY 2025 (ended Dec 31, 2025) · BBWI FY 2026 (ended Jan 31, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 38% equity / 62% debt · EV / Revenue 4.54x · EV / EBITDA 27.06x
Capital structure 49% equity / 51% debt · EV / Revenue 0.98x · EV / EBITDA 5.07x
BBWI carries the larger enterprise value at $7.15B against $2.13B; BBWI trades on the lower EV / Revenue multiple (0.98x vs 4.54x); BBWI on the lower EV / EBITDA (5.07x vs 27.06x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
HIPPO HOLDINGS INC. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
BATH & BODY WORKS, INC. · implied price per share
Bear
$26.50
Base
$31.55
Bull
$40.51
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
3.33x
-3.26x
Net debt / EBITDA
Leverage against operating earnings
15.70x
2.28x
Cash and equivalents
Liquid reserves on the balance sheet
$218.30M
$953.00M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Lemonade, Inc.
HIPO vs LMND
PROASSURANCE CORP
HIPO vs PRA
CNA FINANCIAL CORP
HIPO vs CNA
RLI CORP
HIPO vs RLI
Victoria's Secret & Co.
HIPO vs VSCO
ABERCROMBIE & FITCH CO /DE/
HIPO vs ANF
ESTEE LAUDER COMPANIES INC
HIPO vs EL
Ulta Beauty, Inc.
HIPO vs ULTA
Sally Beauty Holdings, Inc.
HIPO vs SBH
$1.45B
$4.17B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
